RNA Avidity Biosciences, Inc. Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
10:50
Sep 08
A May MD Biotech investor
The author notes RNA's failure for Novartis compounds Friday's Lp(a) setback.
The author notes RNA's failure for Novartis compounds Friday's Lp(a) setback, questioning if this could trigger the company's largest selloff ever.
RNA
LOW
05:31
Sep 08
seedy19tron Biotech trader, L/S
The author thanks another user for highlighting MOR and RNA but expresses no personal position.
The author thanks another user for highlighting MOR and RNA but expresses no personal position or directional view.
RNA
LOW
14:20
Sep 03
A May MD Biotech investor
RNA cited as fast post-data M&A
Cites RNA's post-data M&A as the fastest recent large-deal precedent, used as a timing benchmark for ABVX; no directional RNA view.
RNA
MED

About RNA Analyst Coverage

Buzzberg tracks RNA (Avidity Biosciences, Inc.) across 2 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 3 total trade ideas tracked. Past 7 days: 3 watch. Latest voices: A May MD, seedy19tron.